- Research works
- 85 ▼ 15% vs 2013–17
- Citations
- 3k 34.7 per fractional work
- Top-10% rate
- 20.6% record average 16.5%
- Open access
- 61% world 28%
Not ranked overall: Macrogen (South Korea) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 8.8×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 8.8×
- Biochemistry, Genetics and Molecular Biology 6.0×
- Immunology and Microbiology 5.2×
- Agricultural and Biological Sciences 3.2×
- Materials Science 1.4×
- Medicine 1.4×
- Physics and Astronomy 1.1×
- Neuroscience 1.1×
- Chemistry 0.8×
- Environmental Science 0.7×
- Earth and Planetary Sciences 0.4×
- Social Sciences 0.2×
- Mathematics 0.2×
- Arts and Humanities 0.1×
- Engineering 0.0×
Which keywords describe research at Macrogen (South Korea)?
By fractional works in all years, weighted toward what it does more of than the world: Gene Expression, Targeted Therapy, Cancer, Cell-Free DNA, Genomic Instability, Cancer Genomics, Mutational Signatures and Phylogenetic Analysis.
- Cancer Progression
- Breast Cancer
- Genetic Variation
- Precision Medicine
- Epigenetic Regulation
- ALK Inhibitors
- Genomic Profiling
- Differential Expression
- Cancer Risk
- Genomic Rearrangements
- Biomarkers
- sequence alignment
- Clinical Trials
- Functional Genomics
- Data Analysis
- Oxidative Stress
- Phylogenetic Analysis
- Cancer Genomics
- Cell-Free DNA
- Targeted Therapy
- Gene Expression
- Cancer
- Genomic Instability
- Mutational Signatures
- Inflammation
- RNA-Seq
- Normalization
- Bioinformatics
- genome annotation
- Neurodevelopmental Disorders
- Copy Number Variation
- Metastasis
- Chemotherapy
- Microarray
- Regulation
- EGFR Mutations
- Genetic Testing
- Treatment Guidelines
- Tumor Microenvironment
- Molecular Characterization
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Gene Expression8▲ 15×12 topics
- Targeted Therapy8▲ 42×4 topics
- Cancer7▲ 5.5×25 topics
- Cell-Free DNA6▲ 72×2 topics
- Genomic Instability5▲ 48×3 topics
- Cancer Genomics5▲ 108×1 topic
- Mutational Signatures5▲ 108×1 topic
- Phylogenetic Analysis4▲ 14×6 topics
- Inflammation4▲ 2.1×26 topics
- Oxidative Stress4▲ 2.4×16 topics
- RNA-Seq4▲ 45×2 topics
- Data Analysis3▲ 12×3 topics
- Normalization3▲ 53×2 topics
- Functional Genomics3▲ 40×2 topics
- Bioinformatics3▲ 32×4 topics
- Clinical Trials3▲ 5.9×7 topics
- genome annotation3▲ 49×1 topic
- sequence alignment3▲ 49×1 topic
- Neurodevelopmental Disorders3▲ 23×2 topics
- Biomarkers3▲ 5.4×10 topics
- Copy Number Variation3▲ 137×1 topic
- Genomic Rearrangements3▲ 123×1 topic
- Metastasis2▲ 8.5×8 topics
- Cancer Risk2▲ 11×5 topics
- Chemotherapy2▲ 3.9×8 topics
- Differential Expression2▲ 88×1 topic
- Microarray2▲ 88×1 topic
- Genomic Profiling2▲ 24×2 topics
- Regulation2▲ 4.0×7 topics
- ALK Inhibitors2▲ 41×1 topic
- EGFR Mutations2▲ 41×1 topic
- Epigenetic Regulation2▲ 11×5 topics
- Genetic Testing2▲ 14×2 topics
- Precision Medicine2▲ 7.7×6 topics
- Treatment Guidelines2▲ 11×2 topics
- Genetic Variation2▲ 7.3×5 topics
- Tumor Microenvironment2▲ 5.8×7 topics
- Breast Cancer2▲ 7.0×5 topics
- Molecular Characterization2▲ 11×5 topics
- Cancer Progression2▲ 8.0×4 topics
Which research topics does Macrogen (South Korea) publish most on?
By volume in 2022–2025: Single-cell and spatial transcriptomics, Atherosclerosis and Cardiovascular Diseases, Gut microbiota and health and Cancer Immunotherapy and Biomarkers.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Single-cell and spatial transcriptomics Molecular Biology 1 works
- 2 Atherosclerosis and Cardiovascular Diseases Immunology 0 works
- 3 Gut microbiota and health Molecular Biology 0 works
- 4 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 5 Genomics and Rare Diseases Genetics 0 works
- 6 Cancer Genomics and Diagnostics Cancer Research 0 works
- 7 Pharmacogenetics and Drug Metabolism Pharmacology 0 works
- 8 Berberine and alkaloids research Pharmacology 0 works
- 9 Catalytic Processes in Materials Science Materials Chemistry 0 works
- 10 Photonic Crystals and Applications Atomic and Molecular Physics, and Optics 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Macrogen (South Korea)'s research output changed?
Output in 2018–2022 was 15% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Seoul
- Seoul National University
- Yonsei University
- Korea University
- Sungkyunkwan University
- Hanyang University
- Kyung Hee University
- Chung-Ang University
- Samsung (South Korea)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.